About this Journal Submit a Manuscript Table of Contents
Oxidative Medicine and Cellular Longevity
Volume 2012 (2012), Article ID 670294, 9 pages
http://dx.doi.org/10.1155/2012/670294
Review Article

Oxidative Stress and Immunosenescence: Therapeutic Effects of Melatonin

Department of Physiology, Neuroimmunophysiology and Chrononutrition Research Group, Faculty of Science, University of Extremadura, 06006 Badajoz, Spain

Received 9 October 2012; Accepted 13 December 2012

Academic Editor: Sumitra Miriyala

Copyright © 2012 Javier Espino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Semsei, “On the nature of aging,” Mechanisms of Ageing and Development, vol. 117, no. 1–3, pp. 93–108, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Harman, “Aging: a theory based on free radical and radiation chemistry,” Journal of gerontology, vol. 11, no. 3, pp. 298–300, 1956. View at Scopus
  3. R. J. Reiter, S. D. Paredes, A. Korkmaz, L. C. Manchester, and D. X. Tan, “Melatonin in relation to the ‘strong’and ‘weak’versions of the free radical theory of aging,” Advances in Medical Sciences, vol. 53, pp. 119–129, 2008. View at Publisher · View at Google Scholar
  4. D. Harman, “The biologic clock: the mitochondria?” Journal of the American Geriatrics Society, vol. 20, no. 4, pp. 145–147, 1972. View at Scopus
  5. D. Harman, “Free radical theory of aging: an update—increasing the functional life span,” Annals of the New York Academy of Sciences, vol. 1067, no. 1, pp. 10–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. F. L. Muller, M. S. Lustgarten, Y. Jang, A. Richardson, and H. van Remmen, “Trends in oxidative aging theories,” Free Radical Biology and Medicine, vol. 43, no. 4, pp. 477–503, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. S. Lustgarten, Y. C. Jang, Y. Liu et al., “MnSOD deficiency results in elevated oxidative stress and decreased mitochondrial function but does not lead to muscle atrophy during aging,” Aging Cell, vol. 10, no. 3, pp. 493–505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Jou, T. I. Peng, R. J. Reiter, S. B. Jou, H. Y. Wu, and S. T. Wen, “Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes,” Journal of Pineal Research, vol. 37, no. 1, pp. 55–70, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Jou, T. I. Peng, P. Z. Yu et al., “Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis,” Journal of Pineal Research, vol. 43, no. 4, pp. 389–403, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Sies, “Oxidative stress: introductory remarks,” in Oxidative Stress, H. Sies, Ed., pp. 1–8, Academic, London, UK, 1985.
  11. A. D. Bolzán, M. S. Bianchi, and N. O. Bianchi, “Superoxide dismutase, catalase and glutathione peroxidase activities in human blood: influence of sex, age and cigarette smoking,” Clinical Biochemistry, vol. 30, no. 6, pp. 449–454, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. M. E. Inal, G. Kanbak, and E. Sunal, “Antioxidant enzyme activities and malondialdehyde levels related to aging,” Clinica Chimica Acta, vol. 305, no. 1-2, pp. 75–80, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Kȩdziora-Kornatowska, K. Szewczyk-Golec, J. Czuczejko et al., “Effect of melatonin on the oxidative stress in erythrocytes of healthy young and elderly subjects,” Journal of Pineal Research, vol. 42, no. 2, pp. 153–158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Kasapoglu and T. Özben, “Alterations of antioxidant enzymes and oxidative stress markers in aging,” Experimental Gerontology, vol. 36, no. 2, pp. 209–220, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. J. Reiter, D. X. Tan, C. Osuna, and E. Gitto, “Actions of melatonin in the reduction of oxidative stress: a review,” Journal of Biomedical Science, vol. 7, no. 6, pp. 444–458, 2000. View at Scopus
  16. R. J. Reiter, J. R. Calvo, M. Karbownik, W. Qi, and D. X. Tan, “Melatonin and its relation to the immune system and inflammation,” Annals of the New York Academy of Sciences, vol. 917, pp. 376–386, 2000. View at Scopus
  17. A. K. Hotchkiss and R. J. Nelson, “Melatonin and immune function: hype or hypothesis?” Critical Reviews in Immunology, vol. 22, no. 5-6, pp. 351–371, 2002. View at Scopus
  18. A. I. Esquifino, S. R. Pandi-Perumal, and D. P. Cardinali, “Circadian organization of the immune response: a role for melatonin,” Clinical and Applied Immunology Reviews, vol. 4, no. 6, pp. 423–433, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Pawelec, A. Akbar, C. Caruso, R. Effros, B. Grubeck-Loebenstein, and A. Wikby, “Is immunosenescence infectious?” Trends in Immunology, vol. 25, no. 8, pp. 406–410, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. F. T. Hakim, F. A. Flomerfelt, M. Boyiadzis, and R. E. Gress, “Aging, immunity and cancer,” Current Opinion in Immunology, vol. 16, no. 2, pp. 151–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Wessels, J. Jansen, L. Rink, and P. Uciechowski, “Immunosenescence of polymorphonuclear neutrophils,” TheScientificWorldJournal, vol. 10, pp. 145–160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Franceschi, M. Bonafè, S. Valensin et al., “Inflamm-aging. An evolutionary perspective on immunosenescence,” Annals of the New York Academy of Sciences, vol. 908, pp. 244–254, 2000. View at Scopus
  23. E. A. Rich, M. A. Mincek, K. B. Armitage et al., “Accessory function and properties of monocytes from healthy elderly humans for T lymphocyte responses to mitogen and antigen,” Gerontology, vol. 39, no. 2, pp. 93–108, 1993. View at Scopus
  24. G. Pawelec, “Immunosenescence: impact in the young as well as the old?” Mechanisms of Ageing and Development, vol. 108, no. 1, pp. 1–7, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Franceschi, S. Valensin, F. Fagnoni, C. Barbi, and M. Bonafè, “Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load,” Experimental Gerontology, vol. 34, no. 8, pp. 911–921, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. P. J. Linton, L. Haynes, L. Tsui, X. Zhang, and S. Swain, “From naive to effector—alterations with aging,” Immunological Reviews, vol. 160, pp. 9–18, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Fulop Jr., G. Foris, I. Worum, G. Paragh, and A. Leövey, “Age related variations of some polymorphonuclear leukocyte functions,” Mechanisms of Ageing and Development, vol. 29, no. 1, pp. 1–8, 1985. View at Publisher · View at Google Scholar · View at Scopus
  28. J. M. Lord, S. Butcher, V. Killampali, D. Lascelles, and M. Salmon, “Neutrophil ageing and immunesenescence,” Mechanisms of Ageing and Development, vol. 122, no. 14, pp. 1521–1535, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Miyaji, H. Watanabe, H. Toma et al., “Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians,” Human Immunology, vol. 61, no. 9, pp. 908–916, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Bonafè, S. Valensin, W. Gianni, V. Marigliano, and C. Franceschi, “The unexpected contribution of immunosenescence to the leveling off of cancer incidence and mortality in the oldest old,” Critical Reviews in Oncology/Hematology, vol. 39, no. 3, pp. 227–233, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Ginaldi, M. de Martinis, A. D'Ostilio, L. Marini, M. F. Loreto, and D. Quaglino, “The immune system in the elderly: III. Innate immunity,” Immunologic Research, vol. 20, no. 2, pp. 117–126, 1999. View at Scopus
  32. V. Srinivasan, G. J. M. Maestroni, D. P. Cardinali, A. I. Esquifino, S. R. Pandi Perumal, and S. C. Miller, “Melatonin, immune function and aging,” Immunity and Ageing, vol. 2, article 17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Mariani, L. Pulsatelli, A. Meneghetti et al., “Different IL-8 production by T and NK lymphocytes in elderly subjects,” Mechanisms of Ageing and Development, vol. 122, no. 13, pp. 1383–1395, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. J. W. Albright, J. H. Bream, E. W. Bere, H. A. Young, R. Winkler-Pickett, and J. R. Ortaldo, “Aging of innate immunity: functional comparisons of NK/LAK cells obtained from bulk cultures of young and aged mouse spleen cells in high concentrations of interleukin-2,” Experimental Gerontology, vol. 39, no. 1, pp. 73–82, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. M. C. Haigis and B. A. Yankner, “The aging stress response,” Molecular Cell, vol. 40, no. 2, pp. 333–344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Nomellini, C. Gomez, and E. Kovacs, “Aging and impairment of innate immunity,” Contributions to Microbiology, vol. 15, pp. 188–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Fujimoto, H. Kobayashi, and M. Ohno, “Age-induced reduction in mitochondrial manganese superoxide dismutase activity and tolerance of macrophages against apoptosis induced by oxidized low density lipoprotein,” Circulation Journal, vol. 74, no. 2, pp. 353–360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. de la Fuente, A. Hernanz, N. Guayerbas, P. Alvarez, and C. Alvarado, “Changes with age in peritoneal macrophage functions. Implication of leukocytes in the oxidative stress of senescence,” Cellular and Molecular Biology, vol. 50, pp. 683–690, 2004. View at Scopus
  39. E. S. Cannizzo, C. C. Clement, R. Sahu, C. Follo, and L. Santambrogio, “Oxidative stress, inflamm-aging and immunosenescence,” Journal of Proteomics, vol. 74, pp. 2313–2323, 2011. View at Publisher · View at Google Scholar
  40. A. Larbi, G. Dupuis, N. Douziech, A. Khalil, and T. Fülöp, “Low-grade inflammation with aging has consequences for T-lymphocyte signaling,” Annals of the New York Academy of Sciences, vol. 1030, pp. 125–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Tomoiu, A. Larbi, C. Fortin, G. Dupuis, and T. Fulop, “Do membrane rafts contribute to human immunosenescence?” Annals of the New York Academy of Sciences, vol. 1100, pp. 98–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Julius, L. Abernathy, and R. Yung, “Defective dendritic cell phagocytic function in aging,” The Journal of Immunology, vol. 182, pp. 134–136, 2009.
  43. S. Ponnappan, H. Ovaa, and U. Ponnappan, “Lower expression of catalytic and structural subunits of the proteasome contributes to decreased proteolysis in peripheral blood T lymphocytes during aging,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 4, pp. 799–809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Larbi, J. Kempf, and G. Pawelec, “Oxidative stress modulation and T cell activation,” Experimental Gerontology, vol. 42, no. 9, pp. 852–858, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. D. A. Rider, A. J. Sinclair, and S. P. Young, “Oxidative inactivation of CD45 protein tyrosine phosphatase may contribute to T lymphocyte dysfunction in the elderly,” Mechanisms of Ageing and Development, vol. 124, no. 2, pp. 191–198, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Spaulding, W. Guo, and R. B. Effros, “Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation,” Experimental Gerontology, vol. 34, no. 5, pp. 633–644, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Giovannetti, M. Pierdominici, A. Di Iorio et al., “Apoptosis in the homeostasis of the immune system and in human immune mediated diseases,” Current Pharmaceutical Design, vol. 14, no. 3, pp. 253–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. M. de Martinis, C. Franceschi, D. Monti, and L. Ginaldi, “Apoptosis remodeling in immunosenescence: implications for strategies to delay ageing,” Current Medicinal Chemistry, vol. 14, no. 13, pp. 1389–1397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Espino, I. Bejarano, S. D. Paredes et al., “Melatonin counteracts alterations in oxidative metabolism and cell viability induced by intracellular calcium overload in human leucocytes: changes with age,” Basic and Clinical Pharmacology and Toxicology, vol. 107, no. 1, pp. 590–597, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Espino, I. Bejarano, S. D. Paredes et al., “Melatonin is able to delay endoplasmic reticulum stress-induced apoptosis in leukocytes from elderly humans,” AGE, vol. 33, no. 4, pp. 497–507, 2011. View at Publisher · View at Google Scholar
  51. L. F. Hung, K. Y. Huang, D. H. Yang, D. M. Chang, J. H. Lai, and L. J. Ho, “Advanced glycation end products induce T cell apoptosis: involvement of oxidative stress, caspase and the mitochondrial pathway,” Mechanisms of Ageing and Development, vol. 131, no. 11-12, pp. 682–691, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. A. M. Bassi, S. Ledda, S. Valentini et al., “Damaging effects of advanced glycation end-products in the murine macrophage cell line J774A.1,” Toxicology In Vitro, vol. 16, no. 4, pp. 339–347, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. R. J. Reiter, “Pineal melatonin: cell biology of its synthesis and of its physiological interactions,” Endocrine Reviews, vol. 12, no. 2, pp. 151–180, 1991. View at Scopus
  54. J. Axelrod and H. Weissbach, “Enzymatic O-methylation of N-acetylserotonin to melatonin,” Science, vol. 131, no. 3409, p. 1312, 1960. View at Scopus
  55. R. J. Reiter, “Melatonin: the chemical expression of darkness,” Molecular and Cellular Endocrinology, vol. 79, no. 1–3, pp. C153–C158, 1991. View at Scopus
  56. R. J. Reiter, “The ageing pineal gland and its physiological consequences,” BioEssays, vol. 14, no. 3, pp. 169–175, 1992. View at Scopus
  57. S. Benot, R. Goberna, R. J. Reiter, S. Garcia-Mauriño, C. Osuna, and J. M. Guerrero, “Physiological levels of melatonin contribute to the antioxidant capacity of human serum,” Journal of Pineal Research, vol. 27, no. 1, pp. 59–64, 1999. View at Publisher · View at Google Scholar · View at Scopus
  58. R. J. Reiter, D. X. Tan, S. J. Kim et al., “Augmentation of indices of oxidative damage in life-long melatonin- deficient rats,” Mechanisms of Ageing and Development, vol. 110, no. 3, pp. 157–173, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. M. P. Terrón, S. D. Paredes, C. Barriga, E. Ortega, R. J. Reiter, and A. B. Rodríguez, “Melatonin, lipid peroxidation, and age in heterophils from the ring dove (Streptopelia risoria),” Free Radical Research, vol. 39, no. 6, pp. 613–619, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. R. J. Reiter, D. X. Tan, L. C. Manchester, and M. R. El-Sawi, “Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging,” Annals of the New York Academy of Sciences, vol. 959, pp. 238–250, 2002. View at Scopus
  61. R. M. Sainz, J. C. Mayo, R. J. Reiter, D. X. Tan, and C. Rodriguez, “Apoptosis in primary lymphoid organs with aging,” Microscopy Research and Technique, vol. 62, no. 6, pp. 524–539, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. D. N. Krause, G. G. Geary, S. Doolen, and S. P. Duckles, “Melatonin and cardiovascular function,” Advances in Experimental Medicine and Biology, vol. 460, pp. 299–310, 1999. View at Scopus
  63. E. Peschke, “Melatonin, endocrine pancreas and diabetes,” Journal of Pineal Research, vol. 44, no. 1, pp. 26–40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. J. R. Redman, “Circadian entrainment and phase shifting in mammals with melatonin,” Journal of Biological Rhythms, vol. 12, no. 6, pp. 581–587, 1997. View at Scopus
  65. S. D. Paredes, A. M. Marchena, I. Bejarano et al., “Melatonin and tryptophan affect the activity-rest rhythm, core and peripheral temperatures, and interleukin levels in the ringdove: changes with age,” Journals of Gerontology A, vol. 64, no. 3, pp. 340–350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. I. V. Zhdanova and R. J. Wurtman, “Efficacy of melatonin as a sleep-promoting agent,” Journal of Biological Rhythms, vol. 12, no. 6, pp. 644–650, 1997. View at Scopus
  67. J. Arendt, “Does melatonin improve sleep? Efficacy of melatonin,” British Medical Journal, vol. 332, no. 7540, p. 550, 2006. View at Scopus
  68. J. Arendt, D. J. Skene, B. Middleton, S. W. Lockley, and S. Deacon, “Efficacy of melatonin treatment in jet lag, shift work, and blindness,” Journal of Biological Rhythms, vol. 12, no. 6, pp. 604–617, 1997. View at Scopus
  69. D. X. Tan, L. D. Chen, B. Poeggeler, L. C. Manchester, and R. J. Reiter, “Melatonin: a potent, endogenous hydroxyl radical scavenger,” Journal of Endocrinology, vol. 1, pp. 57–60, 1993.
  70. A. B. Rodriguez, G. Nogales, J. M. Marchena, E. Ortega, and C. Barriga, “Suppression of both basal and antigen-induced lipid peroxidation in ring dove heterophils by melatonin,” Biochemical Pharmacology, vol. 58, no. 8, pp. 1301–1306, 1999. View at Publisher · View at Google Scholar · View at Scopus
  71. M. P. Terrón, J. Ma Marchena, F. Shadi, S. Harvey, R. W. Lea, and A. B. Rodriguez, “Melatonin: an antioxidant at physiological concentrations,” Journal of Pineal Research, vol. 31, no. 1, pp. 95–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. D. X. Tan, L. C. Manchester, M. P. Terron, L. J. Flores, and R. J. Reiter, “One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?” Journal of Pineal Research, vol. 42, no. 1, pp. 28–42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Winiarska, T. Fraczyk, D. Malinska, J. Drozak, and J. Bryla, “Melatonin attenuates diabetes-induced oxidative stress in rabbits,” Journal of Pineal Research, vol. 40, no. 2, pp. 168–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. D. Pozo, R. J. Reiter, J. R. Calvo, and J. M. Guerrero, “Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum,” Life Sciences, vol. 55, no. 24, pp. PL455–PL460, 1994. View at Publisher · View at Google Scholar · View at Scopus
  75. J. León, D. Acuña-Castroviejo, G. Escames, D. X. Tan, and R. J. Reiter, “Melatonin mitigates mitochondrial malfunction,” Journal of Pineal Research, vol. 38, no. 1, pp. 1–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Leon, D. Acuña-Castroviejo, R. M. Sainz, J. C. Mayo, D. X. Tan, and R. J. Reiter, “Melatonin and mitochondrial function,” Life Sciences, vol. 75, no. 7, pp. 765–790, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Espino, I. Bejarano, P. C. Redondo et al., “Melatonin reduces apoptosis induced by calcium signaling in human leukocytes: evidence for the involvement of mitochondria and bax activation,” Journal of Membrane Biology, vol. 233, no. 1–3, pp. 105–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Espino, I. Bejarano, S. D. Paredes, C. Barriga, A. B. Rodríguez, and J. A. Pariente, “Protective effect of melatonin against human leukocyte apoptosis induced by intracellular calcium overload: relation with its antioxidant actions,” Journal of Pineal Research, vol. 51, no. 2, pp. 195–206, 2011. View at Publisher · View at Google Scholar
  79. L. F. Rodella, G. Favero, C. Rossini et al., “Aging and vascular dysfunction: beneficial melatonin effects,” AGE. In press. View at Publisher · View at Google Scholar
  80. R. Cristòfol, D. Porquet, R. Corpas et al., “Neurons from senescence-accelerated SAMP8 mice are protected against frailty by the sirtuin 1 promoting agents melatonin and resveratrol,” Journal of Pineal Research, vol. 52, no. 3, pp. 271–281, 2012. View at Publisher · View at Google Scholar
  81. M. Tajes, J. Gutierrez-Cuesta, D. Ortuño-Sahagun, A. Camins, and M. Pallàs, “Anti-aging properties of melatonin in an in vitro murine senescence model: involvement of the sirtuin 1 pathway,” Journal of Pineal Research, vol. 47, no. 3, pp. 228–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. J. M. Guerrero and R. J. Reiter, “Melatonin-immune system relationships,” Current Topics in Medicinal Chemistry, vol. 2, no. 2, pp. 167–179, 2002. View at Scopus
  83. G. J. M. Maestroni, A. Conti, and W. Pierpaoli, “Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone,” Journal of Neuroimmunology, vol. 13, no. 1, pp. 19–30, 1986. View at Scopus
  84. G. J. M. Maestroni, A. Conti, and P. Lissoni, “Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4,” Cancer Research, vol. 54, no. 17, pp. 4740–4743, 1994. View at Scopus
  85. G. J. M. Maestroni, V. Covacci, and A. Conti, “Hematopoietic rescue via T-cell-dependent, endogenous granulocyte- macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice,” Cancer Research, vol. 54, no. 9, pp. 2429–2432, 1994. View at Scopus
  86. N. L. Currier, L. Z. Y. Sun, and S. C. Miller, “Exogenous melatonin: quantitative enhancement in vivo of cells mediating non-specific immunity,” Journal of Neuroimmunology, vol. 104, no. 2, pp. 101–108, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. K. M. Morrey, J. A. McLachlan, C. D. Serkin, and O. Bakouche, “Activation of human monocytes by the pineal hormone melatonin,” Journal of Immunology, vol. 153, no. 6, pp. 2671–2680, 1994. View at Scopus
  88. M. J. Barjavel, Z. Mamdouh, N. Raghbate, and O. Bakouche, “Differential expression of the melatonin receptor in human monocytes,” Journal of Immunology, vol. 160, no. 3, pp. 1191–1197, 1998. View at Scopus
  89. F. Liu, T. B. Ng, and M. C. Fung, “Pineal indoles stimulate the gene expression of immunomodulating cytokines,” Journal of Neural Transmission, vol. 108, no. 4, pp. 397–405, 2001. View at Publisher · View at Google Scholar · View at Scopus
  90. S. O. Silva, M. R. Rodrigues, V. F. Ximenes, A. E. B. Bueno-da-Silva, G. P. Amarante-Mendes, and A. Campa, “Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release,” Journal of Neuroimmunology, vol. 156, no. 1-2, pp. 146–152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Carrillo-Vico, S. García-Mauriño, J. R. Calvo, and J. M. Guerrero, “Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor,” The FASEB Journal, vol. 17, no. 6, pp. 755–757, 2003. View at Scopus
  92. S. Garcia-Mauriño, M. G. Gonzalez-Haba, J. R. Calvo et al., “Melatonin enhances IL-2, IL-6, and IFN gamma production by human circulating CD4+ cells: a possible nuclear receptor mediated mechanism involving T helper type 1 lymphocytes and monocytes,” Journal of Immunology, vol. 159, no. 2, pp. 574–581, 1997. View at Scopus
  93. S. Garcia-Mauriño, M. G. Gonzalez-Haba, J. R. Calvo, R. Goberna, and J. M. Guerrero, “Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production by human blood mononuclear cells,” Journal of Neuroimmunology, vol. 92, no. 1-2, pp. 76–84, 1998. View at Publisher · View at Google Scholar · View at Scopus
  94. Q. Yu, S. C. Miller, and D. G. Osmond, “Melatonin inhibits apoptosis during early B-cell development in mouse bone marrow,” Journal of Pineal Research, vol. 29, no. 2, pp. 86–93, 2000. View at Scopus
  95. D. X. Tan, L. C. Manchester, R. J. Reiter et al., “Identification of highly elevated levels of melatonin in bone marrow: its origin and significance,” Biochimica et Biophysica Acta, vol. 1472, no. 1-2, pp. 206–214, 1999. View at Publisher · View at Google Scholar · View at Scopus
  96. Y. M. Tian, G. Y. Zhang, and Y. R. Dai, “Melatonin rejuvenates degenerated thymus and redresses peripheral immune functions in aged mice,” Immunology Letters, vol. 88, no. 2, pp. 101–104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. Y. M. Tian, P. P. Li, X. F. Jiang, G. Y. Zhang, and Y. R. Dai, “Rejuvenation of degenerative thymus by oral melatonin administration and the antagonistic action of melatonin against hydroxyl radical-induced apoptosis of cultured thymocytes in mice,” Journal of Pineal Research, vol. 31, no. 3, pp. 214–221, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. R. M. Sainz, J. C. Mayo, R. J. Reiter, I. Antolín, M. M. Esteban, and C. Rodríguez, “Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus,” The FASEB Journal, vol. 13, no. 12, pp. 1547–1556, 1999. View at Scopus
  99. R. M. Sainz, J. C. Mayo, H. Uría et al., “The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes,” Journal of Pineal Research, vol. 19, no. 4, pp. 178–188, 1995. View at Scopus
  100. C. Tortorella, G. Piazzolla, F. Spaccavento, S. Pece, E. Jirillo, and S. Antonaci, “Spontaneous and fas-induced apoptotic cell death in aged neutrophils,” Journal of Clinical Immunology, vol. 18, no. 5, pp. 321–329, 1998. View at Publisher · View at Google Scholar · View at Scopus
  101. C. Tortorella, O. Simone, G. Piazzolla, I. Stella, V. Cappiello, and S. Antonaci, “Role of phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways in granulocyte macrophage-colony-stimulating factor failure to delay fas-induced neutrophil apoptosis in elderly humans,” Journals of Gerontology A, vol. 61, no. 11, pp. 1111–1118, 2006. View at Scopus
  102. D. Y. Yoo, W. Kim, C. H. Lee et al., “Melatonin improves D-galactose-induced aging effects on behavior, neurogenesis, and lipid peroxidation in the mouse dentate gyrus via increasing pCREB expression,” Journal of Pineal Research, vol. 52, no. 1, pp. 21–28, 2012. View at Publisher · View at Google Scholar
  103. J. Delgado, M. P. Terrón, M. Garrido et al., “Jerte Valley cherry-based product modulates serum inflammatory markers in rats and ringdoves,” Journal of Applied Biomedicine, vol. 10, no. 1, pp. 41–50, 2012. View at Publisher · View at Google Scholar
  104. J. Delgado, M. P. Terrón, M. Garrido et al., “Systemic inflammatory load in young and old ringdoves is modulated by consumption of a Jerte Valley cherry-based product,” Journal of Medicinal Food, vol. 15, no. 8, pp. 707–712, 2012. View at Publisher · View at Google Scholar